Lipoperoxidation is selectively involved in progressive supranuclear palsy

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 5, 2000, Pages 393-397

  Odetti, Patrizio ^a   Garibaldi, Silvano ^a   Norese, Raffaella ^b   Angelini, Giovanna ^b   Marinelli, Lucio ^b   Valentini, Sabina ^a   Menini, Stefano ^b   Traverso, Nicola ^b   Zaccheo, Damiano ^b   Siedlak, Sandra ^c   Perry, George ^c   Smith, Mark A ^c   Tabaton, Massimo ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Neurofibrillary tangles; Oxidative stress; Progressive Supranuclear Palsy; Tau protein

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; NEUROFIBRILLARY TANGLE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY;

EID: 0034098189     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.5.393     Document Type: Article

References (22)

1. Tabaton M. Perry G, Autilio-Gambetti L, Manetto V, Gambetti P. Influence of neural location on antigenic properties of neurofibrillary tangles. Ann Neurol 1988;23:604-10
2. Flament S, Delacourte A, Verny M, Hauw JJ, Javoy-Agid F. Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neuronfibrillary degeneration of Alzheimer type. Acta Neuropathol 1991;81:591-96
3. Smith MA, Harris PLR, Sayre LM, Beckman JS, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997;17:2653-57
4. Smith MA, Taneda S, Richey PL, et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 1994;91:5710-14
5. Yan S-D, Chen X, Schmidt A-M, et al. Glycated tau protein in Alzheimer disease: A mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 1994;91:7787-91
6. Sayre LM, Zelasko DA, Harris PLR, Perry G, Salomon RG, Smith MA. 4-Hydroxy-nonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997;68:2092-97
7. Nunomura A, Perry G, Pappolla MA, et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 1999;19:1959-64
8. Ledesma MD, Bonay P, Colaco C, Avila J. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 1994;269:21614-19
9. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994;77:817-27
10. Perry G, Kawai M, Tabaton M, et al. Neuropil Threads of Alzheimer's disease show a marked alteration in the normal cytoskeleton. J Neurosci 1991;11:1748-55
11. Galloway PG, Perry G, Kosik KS, Gambetti P. Hirano antibodies contain tau protein. Brain Res 1987;403:337-40
12. Young IS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991;28:504-8
13. Nair V, Vietti DE, Cooper CS. Degenerative chemistry of malondialdehyde. Structure, stereochemistry, and kinetics of formation of enaminals from reaction with aminoacids. J Am Chem Soc 1981;103:3030-36
14. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malondialdehyde and 4-hydroxynonenal. Meth Enzymol 1990;186:407-21
15. Montine KS, Kim PJ, Olson SJ, Markesbery WR, Montine TJ. 4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J Neuropathol Exp Neurol 1997;56:866-71
16. Slivka A, Mytilineou C, Cohen G. Histochemical evaluation of glutathione in brain. Brain Res 1987;409:275-84
17. Horie K, Miyata T, Yasuda T, et al. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllsine in lipofuscin pigments of Alzheimer's disease and aged neurons. Biochem Biophys Res Comm 1997;236:327-32
18. Balazs L, Leon M. Evidences of an oxidative challenge in the Alzheimer's brain. Neurochem Res 1990;19:1131-37
19. Smith MA, Kutty RK, Richey PL, et al. Heme oxygenasel is associated with the neurifibrillarypathology of Alzheimer disease. Am J Pathol 1994;145:42-47
20. Smith MA, Rudnicka-Nawrot M, Richey PL, et al. Carbonyl-related post-traslational modification of neurofilament protein in the neurofibillary pathology of Alzheimer's disease. J Neurochem 1995;64:2660-66
21. Lovell MA, Ehmann WD, Butler SM, Markesbery WR. Elevated thiobarbituric acid reactive substance and antioxidant enzyme activity in the brain in the Alzheimer's disease. Neurology 1995;45: 1594-1601
22. Sergeant N, Wattez A, Delacourte A. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. J Neurochem 1999;72:1243-49